Acamptas Tablet 333
By Acamptas
Rx
10 Tablet in a Strip

Composition
Acamprosate(333mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
June, 2027

liver
Caution should be exercised when using Acamptas Tablet 333 in individuals with severe liver disease. It may be necessary to adjust the dosage of the medication, so it is crucial to seek advice from your healthcare provider before starting treatment. There is limited data on the use of Acamptas Tablet 333 in individuals with liver issues, but no dose adjustment is typically required for those with mild to moderate liver disease.

kidney
Acamptas Tablet 333 should be used carefully in patients with kidney disease. A dose adjustment may be necessary, so it's important to consult your doctor. Avoid using this tablet if you have severe kidney disease.

alcohol
Consult your doctor when consuming alcohol with Acamptas Tablet 333.

driving
Acamptas Tablet 333 typically does not impact driving ability.

pregnancy
Acamptas Tablet 333 may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Acamptas Tablet 333 is considered safe during breastfeeding based on limited human data indicating no significant risk to the baby.
| Habit Forming | No |
| Chemical Class | Organosulfonic Acid |
| Therapeutic Class | - |
| Action Class | Alcohol deaddiction |
₹170.66
₹200.78
15% OFF
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025
